clinical trial
News
2023.01.30
Hepatitis is a liver inflammation caused by toxic substances or viruses. There are currently five hepatitis viruses, including hepatitis B virus (HBV), which...
News
2023.01.06
An Institut Pasteur team has successfully developed a pentavalent vaccine against the five pathogenic arenaviruses circulating in South America and tested it...
Document de presse
2022.12.13
Epidemics, pandemics: a never-ending story? – a look back at the conference held on December 7, 2022
In connection with the bicentenary of Louis Pasteur’s birth, a conference entitled "Epidemics, pandemics: a never-ending story?" was held on Wednesday December...
Document de presse
2022.10.20
Although the mechanisms by which SARS-CoV-2 enters host cells are increasingly well documented, the direct molecular interactions between virus and host remain...
News
2022.11.14
Physicians and scientists from the Institut Pasteur, the Pasteur Network and ANRS | Emerging Infectious Diseases have conducted a review of the medical and...
News
2022.10.27
Hospital-acquired infections are a major public health problem. Many such infections, contracted in hospitals and long-term care facilities, are caused by...
Document de presse
2022.10.21
SPK001, the first anti-SARS Cov2 monoclonal antibody candidate of SpikImm, a French biotechnology company founded by Truffle Capital, originally discovered by...
News
2022.09.05
We are looking for volunteers to take part in the CORSER-5 study. The study was launched in March 2022 to compare the immunity of COVID-19-positive individuals...
News
2022.08.25
Scientists at the Institut Pasteur demonstrated in 2003 that there is a genetic component in autism. The same team has now studied the impact of various...
Document de presse
2022.07.22
The team in the Hematology Department at Henri Mondor AP-HP Hospital, coordinated by Dr. Christine Robin, and scientists from the Institut Pasteur (the...